Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically…
Background: Depressive disorders contribute to an excruciating global mental health burden. Recently, there has been a great shift in interest towards substances with psychedelic potential as treatment for patients with resistant forms of depression, one of these substances being psilocybin. The…
Read More...
Read More...